导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -27.06% | 1036/1050 |
| 近一周 | -3.50% | 983/1104 |
| 近一月 | -3.23% | 563/1103 |
| 近一季 | -8.16% | 625/1092 |
| 近半年 | -20.10% | 1001/1070 |
| 近一年 | -17.42% | 857/1018 |
| 近两年 | 8.68% | 844/926 |
| 近三年 | -12.18% | 740/834 |
| 成立以来 | 155.41% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-14.72% 1051/1070 |
-11.46% 946/1101 |
- - |
- - |
| 2025 | 20.45% 663/1065 |
-5.70% 994/1014 |
7.73% 172/1038 |
4.81% 937/1050 |
13.12% 29/1065 |
| 2024 | 13.97% 198/1011 |
6.06% 85/960 |
-5.65% 670/983 |
14.86% 240/991 |
-0.84% 372/1011 |
| 2023 | -25.68% 778/952 |
-2.62% 739/880 |
-10.44% 782/895 |
-6.38% 383/915 |
-8.98% 811/952 |
| 2022 | 6.90% 8/867 |
-12.23% 154/773 |
11.03% 225/806 |
-0.76% 20/845 |
10.53% 70/867 |
| 2021 | 9.73% 254/740 |
-11.72% 520/580 |
39.13% 14/659 |
-5.46% 371/704 |
-5.49% 605/740 |
| 2020 | 73.98% 123/554 |
1.62% 119/419 |
30.10% 131/466 |
5.76% 347/517 |
24.43% 74/554 |
| 2019 | - - |
- - |
1.98% 166/1231 |
9.75% 117/390 |
7.49% 261/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 金信消费升级股票C VS. 东吴新产业精选股票A(580008) |